Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia, Armenia, and South Africa and in a multicountry st...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Emerg Infect Dis
Main Authors: Mbuagbaw, Lawrence, Guglielmetti, Lorenzo, Hewison, Catherine, Bakare, Nyasha, Bastard, Mathieu, Caumes, Eric, Fréchet-Jachym, Mathilde, Robert, Jérôme, Veziris, Nicolas, Khachatryan, Naira, Kotrikadze, Tinatin, Hayrapetyan, Armen, Avaliani, Zaza, Schünemann, Holger J., Lienhardt, Christian
Formato: Artigo
Idioma:Inglês
Publicado: Centers for Disease Control and Prevention 2019
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478224/
https://ncbi.nlm.nih.gov/pubmed/31002070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2505.181823
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares